1. 同济大学附属上海市第四人民医院中医科,上海,200082
2. 上海中医药大学附属岳阳中西医结合医院泌尿科,上海,200437
扫 描 看 全 文
要全保, 彭煜, 朱艳, 等. 通瘀方预防前列腺癌去势治疗后心脑血管事件的临床观察[J]. 上海中医药杂志, 2018,52(10):45-48.
YAO Quanbao, PENG Yu, ZHU Yan, et al. Clinical observation of Tongyu Decoction in preventing cardiovascular events after castration of prostate cancer[J]. Shanghai Journal of Traditional Chinese Medicine, 2018,52(10):45-48.
要全保, 彭煜, 朱艳, 等. 通瘀方预防前列腺癌去势治疗后心脑血管事件的临床观察[J]. 上海中医药杂志, 2018,52(10):45-48. DOI: 10.16305/j.1007-1334.2018.10.012.
YAO Quanbao, PENG Yu, ZHU Yan, et al. Clinical observation of Tongyu Decoction in preventing cardiovascular events after castration of prostate cancer[J]. Shanghai Journal of Traditional Chinese Medicine, 2018,52(10):45-48. DOI: 10.16305/j.1007-1334.2018.10.012.
目的:观察通瘀方对前列腺癌去势治疗后心脑血管事件的预防作用。 方法:将110例前列腺癌患者随机分为治疗组与对照组,每组55例。对照组予去势治疗,治疗组在对照组治疗措施基础上加服通瘀方。两组疗程均为3个月,随访6个月,观察心脑血管事件及终点事件发生情况,比较心脑血管事件相关指标胰岛素(FINS)、空腹血糖(FBG)、颈总动脉内膜中层厚度(IMT)、高灵敏性C反应蛋白(hs-CRP)的变化情况。 结果:①研究期间,对照组发生心脑血管事件14人次(脑梗死1人次、脑出血2人次、颅内腔隙性病灶9人次、心肌梗死1人次、心绞痛1人次,其中脑出血和心肌梗死各死亡1例),发生率为25.45%;治疗组发生心脑血管事件4人次(均为颅内腔隙性病灶,无死亡病例),发生率为7.27%。组间心脑血管事件发生率比较,差异有统计学意义(P<0.05),治疗组明显低于对照组。②治疗前后组内比较,治疗组IMT、hs-CRP、IRI水平差异有统计学意义,均明显降低(P<0.05);对照组IMT、hs-CRP水平差异有统计学意义(P<0.05),均明显升高。组间治疗后比较,IMT、hs-CRP、IRI水平差异有统计学意义(P<0.05),治疗组对上述指标的改善明显优于对照组。 结论:通瘀方能够明显减少前列腺癌去势治疗后心脑血管事件的发生,与前列腺癌去势治疗起到了很好的协同作用,该作用可能与降低胰岛素抵抗、抑制hs-CRP有关。
Objective:To observe the preventive effects of Tongyu Decoction on cardiovascular events after castration of prostate cancer. Methods110 patients with prostate cancer were randomly divided into the treatment group and control group, 55 cases in each group. The control group was treated with castration therapy, and the treatment group was treated with Tongyu Decoction based on the treatment for the control group, with a treatment course of 3 months and follow-up of 6 months. The occurrences of cardiovascular events and end events were observed. The changes of cardiovascular events related indicators including fasting insulin (FINS), fasting blood glucose (FBG), carotid artery intima-media thickness (IMT) and high sensitivity C-reactive protein (hs-CRP) were compared. Results:①During the research, the cardiovascular events occurred in 14 patients in the control group, including 1 case of cerebral infarction, 2 cases of cerebral hemorrhage, 9 cases of intracranial lacunar lesions, 1 case of myocardial infarction and 1 case of angina (among 1 case of cerebral hemorrhage and 1 case of myocardial infarction were dead), the incidence rate was 25.45%. The cardiovascular events occurred in 4 patients in the treatment group, all of them were observed intracranial lacunar lesions and no one died, the incidence rate was 7.27%. There was statistically significant difference on the incidence rate of cardiovascular events between the two groups, and the incidence rate in the treatment group was obviously lower than that in the control group (P<0.05). ②Compared with treatment before, the levels of IMT, hs-CRP and IRI were decreased in the treatment group after treatment, with statistically significant differences (P<0.05), while the levels of IMT and hs-CRP were increased in the control group after treatment, with statistically significant differences. After treatment, there were statistically significant differences on the levels of IMT, hs-CRP and IRI between the two groups, and the improvement on these indicators in the treatment group was better than that in the control group (P<0.05). Conclusion:Tongyu Decoction can significantly reduce the incidence of cardiovascular events after castration of prostate cancer, and play the synergistic effects with castration therapy for prostate cancer. Its mechanism may be related to decreasing insulin resistance and inhibiting hs-CRP.
前列腺癌去势治疗心脑血管事件通瘀方胰岛素抵抗炎症反应
prostate cancercastration therapycardiovascular eventTongyu Decoctioninsulin resistanceinflammatory reaction
0
浏览量
113
下载量
0
CSCD
1
CNKI被引量
关联资源
相关文章
相关作者
相关机构